期刊文献+

五运六气与类风湿关节炎发病相关性研究 被引量:9

Study on the correlation between five movements and six climates and rheumatoid arthritis
下载PDF
导出
摘要 目的:收集类风湿关节炎(RA)患者出生和发病的五运六气等相关信息,运用运气理论对信息整理、挖掘,总结发生RA运气规律,探讨五运六气与RA发病的相关性。方法:釆用回顾性研究方法,随机收集1866例RA门诊患者,收集其发病和出生时的运气学资料,推算出患者的中运、司天、在泉、主气、客气等,把五运作为5个因素、六气作为6个因素,运用统计学分析2组数据,统计运、气因素出现的频次,观察其发病时的运气特点,分析与RA相关的运气因素,并结合中医理论分析、探讨。结果:RA发病年运特征3水平;发病司天的六因素差异在少阴君火与太阴湿土,发病在泉的六因素差别在少阳相火与阳明燥金;发病主气的六因素差异在太阳寒水与太阴湿土。结论:RA发病五运与阳明燥金关系最小,发病司天与少阴君火及太阴湿土关系最密切,在泉与少阳相火、阳明燥金关系最大,主气与太阳寒水与太阴湿土关系最密切。结论:类风湿发病与五运六气具有一定的相关性。
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2018年第6期778-781,共4页 JOURNAL OF BASIC CHINESE MEDICINE
  • 相关文献

参考文献3

二级参考文献24

  • 1Amett FC, Edworthy SM, Bloeh DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988,31:315-324.
  • 2Saraux A, Berthelot JM, Chalks G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum,2001,44:2485-2491.
  • 3Liao KP, Batra KL, Chibnik L, et al. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis ,2008,67 : 1557-1561.
  • 4Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum, 1981,24: 1308-1315.
  • 5Felson DT, Anderson JJ, Boers M, et al. The American College of Rlaeumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum, 1993,36 : 729 -740.
  • 6van der Heijde DM, van't Hof M, van Riel PL, et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol, 1993,20 : 579- 581,.
  • 7Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: A muhicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum, 2006,54 : 26-37.
  • 8Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab ( a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum,2004,50 : 1400-1411.
  • 9Burmester GR, Mariette X, Montecucco C, et al. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice : the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis ,2007,66:732-739.
  • 10Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum,1995,38:44-48.

共引文献28

同被引文献122

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部